Is the diagnostic performance of FFRangio affected by coronary microvascular dysfunction?

Takuya Makita1, Hiroyuki Omori2, Yusuke Miyazaki3

  • 1Department of Clinical Engineering, Gifu Prefectural General Medical Center, Gifu, Japan.

Summary

FFRangio, a non-invasive tool for assessing coronary artery disease, shows reduced accuracy in patients with coronary microvascular dysfunction (CMD). Its diagnostic performance is significantly lower in high-IMR (index of microcirculatory resistance) groups, indicating CMD impacts its reliability.